Results 1 to 10 of about 112,374 (313)

Interpretation of the Essential Updates in 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure [PDF]

Zhongguo quanke yixue, 2022
The American Heart Association (AHA) , American College of Cardiology (ACC) and Heart Failure Society of America (HFSA) jointly released the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure (hereinafter referred to as the 2022 Guideline) .
Yifang GUO
doaj   +1 more source

Association of Depression and Anxiety with Cardiac Structural and Functional Characteristics in Heart Failure with Reduced and Mildly Reduced Ejection Fraction

Clinics and Practice, 2023
Heart failure and mental health conditions frequently coexist and have a negative impact on health-related quality of life and prognosis. We aimed to evaluate depression and anxiety symptoms and to determine the association between psychological distress
Timea Magdolna Szabo, Előd Ernő Nagy, Ádám Kirchmaier, Erhard Heidenhoffer, Hunor-László Gábor-Kelemen, Marius Frăsineanu, Attila Frigy   +6 more
doaj   +1 more source

Metabolomics and a Breath Sensor Identify Acetone as a Biomarker for Heart Failure

Biomolecules, 2022
Background: Multi-omics delivers more biological insight than targeted investigations. We applied multi-omics to patients with heart failure with reduced ejection fraction (HFrEF).
Patrick A. Gladding, Maxine Cooper, Renee Young, Suzanne Loader, Kevin Smith, Erica Zarate, Saras Green, Silas G. Villas Boas, Phillip Shepherd, Purvi Kakadiya, Eric Thorstensen, Christine Keven, Margaret Coe, Mia Jüllig, Edmond Zhang, Todd T. Schlegel   +15 more
doaj   +1 more source

Diabetic microvascular complications predicts non‐heart failure with reduced ejection fraction in type 2 diabetes

ESC Heart Failure, 2023
Aims The relationship between diabetic microvascular complications and the incidence of two types of heart failure—heart failure with reduced ejection fraction (HFrEF) (left ventricular ejection fraction [LVEF] 
Mayu Tochiya, Hisashi Makino, Tamiko Tamanaha, Yoko Omura‐Ohata, Masaki Matsubara, Ryo Koezuka, Michio Noguchi, Tsutomu Tomita, Yasuhide Asaumi, Yoshihiro Miyamoto, Satoshi Yasuda, Kiminori Hosoda   +11 more
doaj   +1 more source

Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides

Frontiers in Cardiovascular Medicine, 2021
This review summarizes current knowledge regarding clinical epidemiology, pathophysiology, and prognosis for patients with HFmrEF in comparison to HFrEF and HFpEF. Although recommended treatments currently focus on aggressive management of comorbidities,
Kaiyuan Zhu, Teng Ma, Yang Su, Xin Pan, Rongrong Huang, Fenglei Zhang, Chunxi Yan, Dachun Xu, Dachun Xu   +8 more
doaj   +1 more source

Understanding How Heart Metabolic Derangement Shows Differential Stage Specificity for Heart Failure with Preserved and Reduced Ejection Fraction

Biomolecules, 2022
Heart failure (HF) is a clinical condition defined by structural and functional abnormalities in the heart that gradually result in reduced cardiac output (HFrEF) and/or increased cardiac pressures at rest and under stress (HFpEF).
Federico Ferro, Renza Spelat, Camilla Valente, Paolo Contessotto   +3 more
doaj   +1 more source

Five‐year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort

ESC Heart Failure, 2022
Aims Available evidence is incomplete and inconsistent in the outcomes of heart failure (HF) patients with preserved ejection fraction (HFpEF), mildly reduced ejection fraction (HFmrEF), and reduced ejection fraction (HFrEF).
Shiqun Chen, Zhidong Huang, Yan Liang, Xiaoli Zhao, Xiemuxikaimaier Aobuliksimu, Bo Wang, Yibo He, Yu Kang, Haozhang Huang, Qiang Li, Younan Yao, Xiaozhao Lu, Xiaoxian Qian, Xujing Xie, Jin Liu, Yong Liu   +15 more
doaj   +1 more source

A comparison of clinical outcomes following atrial fibrillation ablation for heart failure patients with preserved or reduced left ventricular function: A systematic review and meta-analysis

Indian Pacing and Electrophysiology Journal, 2022
Background: This review aims to determine if patients who undergo atrial fibrillation (AF) ablation with heart failure with preserved ejection fraction (HFpEF) do better, or worse or the same compared to patients with heart failure with reduced ejection ...
Gaurav Panchal, Chun Shing Kwok, Adrian Morley-Davies, Donah Zachariah, Thanh Phan   +4 more
doaj   +1 more source

Discriminative Value of Serum Irisin in Prediction of Heart Failure with Different Phenotypes among Patients with Type 2 Diabetes Mellitus

Cells, 2022
Recent studies have shown that circulating levels of irisin are prognostic factors in heart failure (HF), but no data are available on the predictive role of irisin in patients with type 2 diabetes mellitus (T2DM) and different phenotypes of HF.
Alexander A. Berezin, Michael Lichtenauer, Elke Boxhammer, Eric Stöhr, Alexander E. Berezin   +4 more
doaj   +1 more source

Sirt1 Activity in PBMCs as a Biomarker of Different Heart Failure Phenotypes

Biomolecules, 2020
Heart Failure (HF) is a syndrome, which implies the existence of different phenotypes. The new categorization includes patients with preserved ejection fraction (HFpEF), mid-range EF (HFmrEF), and reduced EF (HFrEF) but the molecular mechanisms involved ...
Valeria Conti, Graziamaria Corbi, Maria Vincenza Polito, Michele Ciccarelli, Valentina Manzo, Martina Torsiello, Emanuela De Bellis, Federica D’Auria, Gennaro Vitulano, Federico Piscione, Albino Carrizzo, Paola Di Pietro, Carmine Vecchione, Nicola Ferrara, Amelia Filippelli   +14 more
doaj   +1 more source